- Home
- BYAH vs CRIS Comparison
BYAH vs CRIS Comparison
Compare BYAH & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYAH | CRIS |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 2.0M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BYAH | CRIS |
|---|---|---|
| Price | $2.26 | $0.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 92.8K | ★ 174.3K |
| Earning Date | 07-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.05 | $0.34 |
| 52 Week High | $6.64 | $3,360.00 |
Technical Indicators
Market Signals| Indicator | BYAH | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 18.56 |
| Support Level | $1.97 | $0.34 |
| Resistance Level | $3.26 | $5.50 |
| Average True Range (ATR) | 0.29 | 0.08 |
| MACD | -0.02 | 0.98 |
| Stochastic Oscillator | 26.75 | 14.38 |
Price Performance
Historical ComparisonAbout BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.